A Randomized, Double-Blind, Placebo-Controlled, Multi-Center, Phase II Trail Evaluating the Efficacy and Safety of GR1802 Injection in Patients with Moderate to Severe Asthma

NCT06642961 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

150

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: GR1802 injection
DRUG: GR1802 injection
OTHER: Placebo

Sponsor

Genrix (Shanghai) Biopharmaceutical Co., Ltd.